326 related articles for article (PubMed ID: 9023294)
1. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
[TBL] [Abstract][Full Text] [Related]
2. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
3. Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.
Betancur C; Canton M; Burgos A; Labeeuw B; Gully D; Rostène W; Pélaprat D
Eur J Pharmacol; 1998 Feb; 343(1):67-77. PubMed ID: 9551716
[TBL] [Abstract][Full Text] [Related]
4. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
[TBL] [Abstract][Full Text] [Related]
5. Low-affinity neurotensin receptor (NTS2) signaling: internalization-dependent activation of extracellular signal-regulated kinases 1/2.
Gendron L; Perron A; Payet MD; Gallo-Payet N; Sarret P; Beaudet A
Mol Pharmacol; 2004 Dec; 66(6):1421-30. PubMed ID: 15361549
[TBL] [Abstract][Full Text] [Related]
6. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
[TBL] [Abstract][Full Text] [Related]
7. Blockade of neurotensin receptors affects differently hypo-locomotion and catalepsy induced by haloperidol in mice.
Casti P; Marchese G; Casu G; Ruiu S; Pani L
Neuropharmacology; 2004 Jul; 47(1):128-35. PubMed ID: 15165840
[TBL] [Abstract][Full Text] [Related]
8. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
[TBL] [Abstract][Full Text] [Related]
9. Stimulation by neurotensin of (3H)5-hydroxytryptamine (5HT) release from rat frontal cortex slices.
Héaulme M; Leyris R; Soubrié P; Le Fur G
Neuropeptides; 1998 Oct; 32(5):465-71. PubMed ID: 9845009
[TBL] [Abstract][Full Text] [Related]
10. Effects of the selective neurotensin antagonist SR 142948A on 3,4-methylenedioxymethamphetamine-induced behaviours in mice.
Marie-Claire C; Palminteri S; Romualdi P; Noble F
Neuropharmacology; 2008 Jun; 54(7):1107-11. PubMed ID: 18410947
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor.
Gully D; Canton M; Boigegrain R; Jeanjean F; Molimard JC; Poncelet M; Gueudet C; Heaulme M; Leyris R; Brouard A
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):65-9. PubMed ID: 8380498
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin excitation of serotonergic neurons in the rat nucleus raphe magnus: ionic and molecular mechanisms.
Li AH; Yeh TH; Tan PP; Hwang HM; Wang HL
Neuropharmacology; 2001 Jun; 40(8):1073-83. PubMed ID: 11406199
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist-induced internalization.
Hermans E; Octave JN; Maloteaux JM
Mol Pharmacol; 1996 Feb; 49(2):365-72. PubMed ID: 8632771
[TBL] [Abstract][Full Text] [Related]
15. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor.
Chen L; Yung KK; Yung WH
Neuroscience; 2004; 125(4):853-9. PubMed ID: 15120846
[TBL] [Abstract][Full Text] [Related]
17. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization.
Panayi F; Colussi-Mas J; Lambás-Señas L; Renaud B; Scarna H; Bérod A
Neuropsychopharmacology; 2005 May; 30(5):871-9. PubMed ID: 15637639
[TBL] [Abstract][Full Text] [Related]
18. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes.
Labbé-Jullié C; Dubuc I; Brouard A; Doulut S; Bourdel E; Pelaprat D; Mazella J; Martinez J; Rostène W; Costentin J
J Pharmacol Exp Ther; 1994 Jan; 268(1):328-36. PubMed ID: 8301574
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs.
Binder EB; Kinkead B; Owens MJ; Nemeroff CB
Neuropsychopharmacology; 2004 Dec; 29(12):2200-7. PubMed ID: 15328528
[TBL] [Abstract][Full Text] [Related]
20. Involvement of potentially distinct neurotensin receptors in neurotensin-induced stimulation of striatal [3H]dopamine release evoked by KCl versus electrical depolarization.
Heaulme M; Leyris R; Le Fur G; Soubrie P
Neuropharmacology; 1997 Oct; 36(10):1447-54. PubMed ID: 9423933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
